Danaher Corp
DHR
$250.41
Closing
▼-1.07%
1D
▲8.24%
YTD
Market cap
$185.48B
52 week high
$258.38
52 week low
$182.09
Volume
1,088,084
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$185.48B
Analysts' Rating
BUY
Price Target (Mean)
235.25
Total Analysts
21
P/E
45.93
Operating Margin
20.92%
Beta
0.83
Revenue Growth (Annual)
6.85%
52 week high
$258.38
52 week low
$182.09
Div. Yield
0.43%
EPS Annual Growth
1.34
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services that are used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. Its Life Sciences segment offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs, and vaccines. Its Diagnostics segment offers clinical instruments, reagents, consumables, software that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease.
